Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
AssigneeInstitut Pasteur
InventorsNevine El Solh, Jeanine Allignet
Life of this patent
Estimating the term…
Loading patent…
AssigneeInstitut Pasteur
InventorsNevine El Solh, Jeanine Allignet
Estimating the term…
The present invention pertains to polynucleotides derived from staphylococcal genes encoding resistance to streptogramin A or to streptogramin B and chemically related compounds. This invention also relates to the use of the polynucleotides as oligonucleotide primers or probes for detecting Staphylococcal strains that are resistant to streptogramin A or to streptogramin B and related compounds in a biological sample. In another embodiment, the present invention is directed to the full length coding sequences of the staphylococcal genes encoding for resistance to streptogramin A or to streptogramin B from Staphylococcus and to the polypeptides expressed by these full length coding sequences. Further, this invention relates to the use of the expressed polypeptides to produce specific monoclonal or polyclonal antibodies that serve as detection means in order to characterize any staphylococcal strain carrying genes encoding resistance to streptogramin A or to streptogramin B.
A purified polynucleotide comprising the nucleotide sequence selected from the group consisting of SEQ ID NO. 1 or a fragment derived from SEQ ID NO. 1 containing 15 to 40 nucleotides, SEQ ID NO:
A purified peptide comprising the amino acid sequence encoded by the nucleotide sequence selected from the group consisting of SEQ ID NO:
3 A purified peptide comprising the amino acid sequence selected from the group consisting of SEQ ID NO 4 or a fragment derived from SEQ ID NO:
4 A purified polynucleotide comprising the nucleotide sequence of SEQ ID NO. 3 or a fragment derived from SEQ ID NO:
A purified peptide comprising the amino acid sequence encoded by the nucleotide sequence selected of SEQ ID NO:
6 A purified peptide comprising the amino acid sequence of SEQ ID NO:
A purified polynucleotide comprising the nucleotide sequence selected from the group consisting of SEQ ID NO:
8 A purified peptide comprising the amino acid sequence encoded by the nucleotide sequence selected from the group consisting of SEQ ID NO. 2 or a fragment derived from SEQ ID NO 2 containing 15 to 40 nucleotides, SEQ ID NO:
A purified peptide comprising the amino acid sequence selected from the group consisting of SEQ ID NO. 5 or a fragment derived from SEQ ID NO:
10 A composition of polynucleotide sequences useful for the detection of resistance to streptogramins A and/or B and related compounds comprising at least a nucleotide sequence selected from the group consisting of the polynucleotide or gene or cDNA povgaB, vgbB, and vatC.
A composition of polynucleotide sequences useful for the detection of resistance to streptogramin A or streptogramin B and related compounds comprising at least an amino acid sequence from a polypeptide encoded by a polynucleotide selected from the group consisting of the polynucleotide, gene, or cDNA vgaB, vgbB, and vatC.
A composition of polynucleotide sequences encoding resistance to streptogramins and related compounds, or inducing streptogramin resistance in Gram-positive bacteria, wherein said composition comprises at least a nucleotide sequence encoding a molecule containing ATP binding motifs conferring resistance to streptogramin A and related compounds and at least a nucleotide sequence selected from the following sequences:
13 A composition of polynucleotide sequences encoding resistance to streptogramins and related compounds, or inducing streptogramin resistance in Gram-positive bacteria, wherein said composition comprises at least a nucleotide sequence encoding an acetyltransferase conferring resistance to streptogramin A and related compounds and at least a nucleotide sequence selected from the following sequences
14 A composition of polynucleotide sequences encoding resistance to streptogramins and related compounds, or inducing streptogramin resistance in particular in Gram-positive bacteria, wherein said composition comprises at least a nucleotide sequence encoding a lactonase conferring resistance to streptogramin B and related compounds and at least a nucleotide sequence selected from the following sequences:
15 A composition of polynucleotide sequences according to any one of the claims 12 to 14, wherein the polynucleotide sequence encoding a molecule containing ATP binding motifs confers resistance to streptogramin A and related compounds in Staphylococcus, and wherein the polynucleotide corresponds to a vgaB nucleotide sequence represented in the SEQ ID NO:
16 A composition of claim 15, wherein the polynucleotide sequence encoding a molecule containing ATP binding motifs confers resistance to streptogramin A and related compounds in Staphylococcus aureus
17 A composition of polynucleotide sequences according to any one of the claims 12 to 14, wherein the polynucleotide sequence encoding an acetyltransferase confers resistance to streptogramin A and related compounds in Staphylococcus, and wherein the polynucleotide corresponds to a iaiC nucleotide sequence represented in the SEQ ID NO:
18 A composition of claim 17, wherein the polynucleotide sequence encoding an acetyltransferase confers resistance to streptogramin A and related compounds in Staphylococcus cohnii.
20 A composition of claim 19, wherein the polynucleotide sequence encoding a lactonase confers resistance to streptogramin A and related compounds in Staphylococcus cohnii
21 A composition of polynucleotide sequences according to claim 12 or 13, wherein said composition comprises at least one nucleotide sequence encoding a molecule containing ATP binding motifs conferring resistance to streptogramin A and related and at least one nucleotide sequence encoding an acetyltransferase conferring to streptogramin A and related compounds.
22 A composition of polynucleotide sequences according to claim 21, wherein said composition comprises at least a vgbB nucleotide sequence encoding a molecule containing ATP binding motifs conferring resistance to streptogramin A and related compounds and at least a vatb nucleotide sequence encoding an acetyltransferase conferring resistance to streptogramin A and related compounds
23 A purified polynucleotide that hybridizes specifically under stringent conditions with a polynucleotide sequence selected from the group consisting of SEQ ID NO 1, SEQ ID NO:
24 A polynucleotide fragment comprising at least 10 nucleotides, that hybridizes under stringent conditions with a sequence according to any one of claims 1-9 or 23 or the polynucleotide complementary fragment thereof.
25 A polynucleotide fragment of claim 12, wherein said fragment corresponds to at least one of the following sequences
26 A polynucleotide fragment of claim 12, wherein said fragment corresponds to at least one of the following sequences:
27 A polynucleotide fragment of claim 12, wherein said fragment corresponds to at least one of the following sequences
28 A recombinant DNA sequence comprising at least a nucleotide sequence according to any one of claims 1, 4, or 7 under the control of regulatory elements that regulate the expression of resistance to antibiotics of the streptogramin family in a defined host.
29 A recombinant vector comprising the DNA sequence of claim 31, wherein the vector comprises a plasmid pIP1633 deposited with the C.N.C.M. under the Accession No. I-1768 or a plasmid pIP1714 deposited with the C.N.C M. under the number I-1877 on Jun. 18, 1997.
A recombinant cell host comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO 1, SEQ 11D NO. 11, SEQ ID NO 12, SEQ ID NO 3, SEQ ID NO. 2, SEQ ID NO. 13, and SEQ ID NO. 14, or the recombinant vector ot claim 32.
32 A polynucleotide comprising the full length coding sequence of a Staphylococcus streptogramin A and/or B resistant gene containing a polynucleotide sequence according to any one of claims 1, 4, or 7
33 A monoclonal or polyclonal antibodv directed against a polypeptide or a peptide fragment encoded by the polvnucleotide sequences according to any one of claims 1, 4, or 7.
34 A method of detecting the presence of bacterium harboring the polvnucleotide sequences according to any one of claims 1, 4, or 7 in a biological sample comprising
36 A kit for detecting the presence of bacterium having resistance to streptogramin A and harboring the polynucleotide sequences according to claim 1 or claim 7 in a biological sample, said kit comprising:
37 A method of screening active antibiotics for the treatment of the infections due to Gram-positive bacteria, comprising the steps of:
38 A method of screening for active synthetic molecules capable of penetrating into a bacteria of the family of staphylococci, wherein the inhibiting activity of these molecules is tested on at least a polypeptide encoded by the polynucleotide sequences according to any one of claims 1, 4, or 7 comprising the steps of:
39 An in vitro method of screening for active molecules capable of inhibiting a polypeptide encoded by the polynucleotide sequences according to any one of claims 1, 4, or 7, wherein the inhibiting activity of these molecules is tested on at least said polypeptide, said method comprising the steps of
A composition of a polynucleotide sequence encoding resistance to streptogramins and related compounds, or inducing resistance in Gram-positive bacteria, wherein said composition comprises a nucleotide sequence corresponding to the resistance phenotype of the plasmid pIP163j deposited with the C N.C.M under the Accession No I-1768 and of the plasmid pIP 1680 deposited with the C.N C.M under the Accession No I-1767 and of the plasmid pIP1714 deposited with the C N C M under the number I-1877 on Jun. 18, 1997
41 A method of detecting the presence of bacterium harboring the polynucleotide sequences according to claim 1 or claim 7 in a biological sample, said method comprising the steps of:
42 A diagnostic kit for in vitro detecting the presence of bacterium harboring the polynucleotide sequences according to claim 1 or claim 7 in a biological sample, said kit comprising.
Dependencies are inferred from the claim text.